These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 15708028)
1. Gene expression profiling of renal cell carcinoma and clinical implications. Rogers CG; Tan MH; Teh BT Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028 [No Abstract] [Full Text] [Related]
2. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
3. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival. Sültmann H; von Heydebreck A; Huber W; Kuner R; Buness A; Vogt M; Gunawan B; Vingron M; Füzesí L; Poustka A Clin Cancer Res; 2005 Jan; 11(2 Pt 1):646-55. PubMed ID: 15701852 [TBL] [Abstract][Full Text] [Related]
4. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma]. Küfer R; Hautmann R Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464 [No Abstract] [Full Text] [Related]
5. Gene expression profiling of renal cell carcinoma. Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024 [TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of renal cancer: the journey to clinical application. Ribal MJ Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486 [No Abstract] [Full Text] [Related]
8. Fluorescent cytogenetics of renal cell neoplasms. Brunelli M; Gobbo S; Cossu-Rocca P; Cheng L; Ficarra V; Novara G; Menestrina F; Chilosi M; Martignoni G Pathologica; 2008 Dec; 100(6):454-60. PubMed ID: 19475886 [TBL] [Abstract][Full Text] [Related]
9. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474 [TBL] [Abstract][Full Text] [Related]
10. The role of molecular markers in the staging of renal cell carcinoma. Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS BJU Int; 2007 May; 99(5 Pt B):1208-11. PubMed ID: 17441912 [No Abstract] [Full Text] [Related]
11. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene. Glukhova L; Lavialle C; Fauvet D; Chudoba I; Danglot G; Angevin E; Bernheim A; Goguel AF Oncogene; 2000 Feb; 19(6):754-61. PubMed ID: 10698493 [TBL] [Abstract][Full Text] [Related]
12. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Cheng L; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R Hum Pathol; 2009 Jan; 40(1):10-29. PubMed ID: 19027455 [TBL] [Abstract][Full Text] [Related]